Supplementary Table S2 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials Article Swipe
Rebecca Svanberg Teglgaard
,
Hanne Vibeke Marquart
,
Hans Jakob Hartling
,
Jakob Thaning Bay
,
Caspar da Cunha‐Bang
,
Christian Brieghel
,
Tereza Faitová
,
Lisbeth Enggaard
,
Arnon P. Kater
,
Mark‐David Levin
,
Sabina Kersting
,
Sisse Rye Ostrowski
,
Carsten Utoft Niemann
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.25728685.v1
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.25728685.v1
Supplementary Table S2. Gating strategies for the immune cell subset populations included in this study.
Related Topics
Concepts
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- http://doi.org/10.1158/1078-0432.25728685.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4396543857
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4396543857Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.25728685.v1Digital Object Identifier
- Title
-
Supplementary Table S2 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical TrialsWork title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-05-01Full publication date if available
- Authors
-
Rebecca Svanberg Teglgaard, Hanne Vibeke Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha‐Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P. Kater, Mark‐David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft NiemannList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.25728685.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.25728685.v1Direct OA link when available
- Concepts
-
Chronic lymphocytic leukemia, Innate immune system, Medicine, Table (database), Immune system, Clinical trial, Immunology, Function (biology), Leukemia, Oncology, Internal medicine, Biology, Computer science, Data mining, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4396543857 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.25728685.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.25728685.v1 |
| ids.openalex | https://openalex.org/W4396543857 |
| fwci | |
| type | supplementary-materials |
| title | Supplementary Table S2 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11020 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9695000052452087 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immune Cell Function and Interaction |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777938653 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7148112058639526 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1088156 |
| concepts[0].display_name | Chronic lymphocytic leukemia |
| concepts[1].id | https://openalex.org/C136449434 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5879920721054077 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q428253 |
| concepts[1].display_name | Innate immune system |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5586101412773132 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C45235069 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5137451887130737 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q278425 |
| concepts[3].display_name | Table (database) |
| concepts[4].id | https://openalex.org/C8891405 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4693300127983093 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[4].display_name | Immune system |
| concepts[5].id | https://openalex.org/C535046627 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4648529291152954 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[5].display_name | Clinical trial |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.45568230748176575 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| concepts[7].id | https://openalex.org/C14036430 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4306235909461975 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3736076 |
| concepts[7].display_name | Function (biology) |
| concepts[8].id | https://openalex.org/C2778461978 |
| concepts[8].level | 2 |
| concepts[8].score | 0.42089709639549255 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[8].display_name | Leukemia |
| concepts[9].id | https://openalex.org/C143998085 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3884023427963257 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[9].display_name | Oncology |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.31004080176353455 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C86803240 |
| concepts[11].level | 0 |
| concepts[11].score | 0.20368945598602295 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[11].display_name | Biology |
| concepts[12].id | https://openalex.org/C41008148 |
| concepts[12].level | 0 |
| concepts[12].score | 0.1089850664138794 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[12].display_name | Computer science |
| concepts[13].id | https://openalex.org/C124101348 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0880967378616333 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q172491 |
| concepts[13].display_name | Data mining |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.048286229372024536 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/chronic-lymphocytic-leukemia |
| keywords[0].score | 0.7148112058639526 |
| keywords[0].display_name | Chronic lymphocytic leukemia |
| keywords[1].id | https://openalex.org/keywords/innate-immune-system |
| keywords[1].score | 0.5879920721054077 |
| keywords[1].display_name | Innate immune system |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5586101412773132 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/table |
| keywords[3].score | 0.5137451887130737 |
| keywords[3].display_name | Table (database) |
| keywords[4].id | https://openalex.org/keywords/immune-system |
| keywords[4].score | 0.4693300127983093 |
| keywords[4].display_name | Immune system |
| keywords[5].id | https://openalex.org/keywords/clinical-trial |
| keywords[5].score | 0.4648529291152954 |
| keywords[5].display_name | Clinical trial |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.45568230748176575 |
| keywords[6].display_name | Immunology |
| keywords[7].id | https://openalex.org/keywords/function |
| keywords[7].score | 0.4306235909461975 |
| keywords[7].display_name | Function (biology) |
| keywords[8].id | https://openalex.org/keywords/leukemia |
| keywords[8].score | 0.42089709639549255 |
| keywords[8].display_name | Leukemia |
| keywords[9].id | https://openalex.org/keywords/oncology |
| keywords[9].score | 0.3884023427963257 |
| keywords[9].display_name | Oncology |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.31004080176353455 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/biology |
| keywords[11].score | 0.20368945598602295 |
| keywords[11].display_name | Biology |
| keywords[12].id | https://openalex.org/keywords/computer-science |
| keywords[12].score | 0.1089850664138794 |
| keywords[12].display_name | Computer science |
| keywords[13].id | https://openalex.org/keywords/data-mining |
| keywords[13].score | 0.0880967378616333 |
| keywords[13].display_name | Data mining |
| keywords[14].id | https://openalex.org/keywords/genetics |
| keywords[14].score | 0.048286229372024536 |
| keywords[14].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.25728685.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | http://doi.org/10.1158/1078-0432.25728685.v1 |
| locations[1].id | pmh:oai:figshare.com:article/25728685 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Improved_Innate_Immune_Function_in_Patients_with_Chronic_Lymphocytic_Leukemia_Treated_with_Targeted_Therapy_in_Clinical_Trials/25728685 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5025126993 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7779-8397 |
| authorships[0].author.display_name | Rebecca Svanberg Teglgaard |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Rebecca Svanberg Teglgaard |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5078162026 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9740-6522 |
| authorships[1].author.display_name | Hanne Vibeke Marquart |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hanne Vibeke Marquart |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5038827241 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4886-0419 |
| authorships[2].author.display_name | Hans Jakob Hartling |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Hans Jakob Hartling |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5048810325 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1159-4003 |
| authorships[3].author.display_name | Jakob Thaning Bay |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jakob Thaning Bay |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5011876375 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7800-3098 |
| authorships[4].author.display_name | Caspar da Cunha‐Bang |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Caspar da Cunha-Bang |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5028769876 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1816-8106 |
| authorships[5].author.display_name | Christian Brieghel |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Christian Brieghel |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5004265296 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2729-0354 |
| authorships[6].author.display_name | Tereza Faitová |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Tereza Faitová |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5090339651 |
| authorships[7].author.orcid | https://orcid.org/0009-0000-5024-0430 |
| authorships[7].author.display_name | Lisbeth Enggaard |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Lisbeth Enggaard |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5064164625 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3190-1891 |
| authorships[8].author.display_name | Arnon P. Kater |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Arnon P. Kater |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5004217461 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2139-3547 |
| authorships[9].author.display_name | Mark‐David Levin |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Mark-David Levin |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5046107198 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-5205-361X |
| authorships[10].author.display_name | Sabina Kersting |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Sabina Kersting |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5060569928 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5288-3851 |
| authorships[11].author.display_name | Sisse Rye Ostrowski |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Sisse Rye Ostrowski |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5057884204 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-9880-5242 |
| authorships[12].author.display_name | Carsten Utoft Niemann |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Carsten U. Niemann |
| authorships[12].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.1158/1078-0432.25728685.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table S2 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11020 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9695000052452087 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immune Cell Function and Interaction |
| related_works | https://openalex.org/W2066136773, https://openalex.org/W1495541589, https://openalex.org/W2565121077, https://openalex.org/W2486297723, https://openalex.org/W4394360958, https://openalex.org/W2130166758, https://openalex.org/W4386277455, https://openalex.org/W2560008672, https://openalex.org/W579273576, https://openalex.org/W2418031697 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.25728685.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.1158/1078-0432.25728685.v1 |
| primary_location.id | doi:10.1158/1078-0432.25728685.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | http://doi.org/10.1158/1078-0432.25728685.v1 |
| publication_date | 2024-05-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 12 |
| abstract_inverted_index.S2. | 2 |
| abstract_inverted_index.for | 5 |
| abstract_inverted_index.the | 6 |
| abstract_inverted_index.cell | 8 |
| abstract_inverted_index.this | 13 |
| abstract_inverted_index.Table | 1 |
| abstract_inverted_index.Gating | 3 |
| abstract_inverted_index.immune | 7 |
| abstract_inverted_index.subset | 9 |
| abstract_inverted_index.included | 11 |
| abstract_inverted_index.strategies | 4 |
| abstract_inverted_index.populations | 10 |
| abstract_inverted_index.study.</p> | 14 |
| abstract_inverted_index.<p>Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 13 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.46000000834465027 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.09292877 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |